Genscript Biotech Stock

Genscript Biotech Net Change in Cash

Delisted·Jun 18, 2026

Net Change in Cash of Genscript Biotech (1548.HK) as of Aug 23, 2026.

Net Change in Cash

0.00USD

Last updated:

Net Change in Cash of Genscript Biotech is 2026 0.00 USD. Net Change in Cash of Genscript Biotech was 2025 -1.31 B USD. It decreases by % higher compared to the previous year.

The Genscript Biotech Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2017
-12.61 M USD
Jan 1, 2018
370.70 M USD
Jan 1, 2019
-242.16 M USD
Jan 1, 2020
376.66 M USD
Jan 1, 2021
551.91 M USD
Jan 1, 2022
-156.97 M USD
Jan 1, 2023
422.40 M USD
Jan 1, 2024
-1.31 B USD
The Genscript Biotech Net Change in Cash history
YEARNet Change in CashYoY
-1.31 BUSD-411.17%
422.40 MUSD-369.10%
-156.97 MUSD-128.44%
551.91 MUSD+46.53%
376.66 MUSD-255.54%
-242.16 MUSD-165.33%
370.70 MUSD-3,040.44%
-12.61 MUSD-138.50%
32.74 MUSD-58.07%
78.08 MUSD+2,355.44%
3.18 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

On Eulerpool you can find the complete historical development of Net Change in Cash Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Genscript Biotech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genscript Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genscript Biotech